Role of astrocyte-derived tissue-type plasminogen activator in the regulation of endotoxin-stimulated nitric oxide production by microglial cells

GLIA

Volumn 22, Issue 2, 1998, Pages 130-137

  Vincent, Valérie A M ^a   Löwik, Clemens W G M ^b   Verheijen, Jan H ^c   De Bart, Anton C W ^c   Tilders, Fred J H ^a   Van Dam, Anne Marie ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

Author keywords

Astroglia; Microglia; Rat; Transforming growth factor

Indexed keywords

AMILORIDE; APROTININ; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; ENZYME INHIBITOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; SERINE PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; UROKINASE;

ANIMAL; ARTICLE; ASTROCYTE; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MICROGLIA; NEWBORN; NORTHERN BLOTTING; PHYSIOLOGY; RAT; SERODIAGNOSIS;

AMILORIDE; ANIMALS; ANIMALS, NEWBORN; APROTININ; ASTROCYTES; BLOTTING, NORTHERN; CELLS, CULTURED; ENDOTOXINS; ENZYME INHIBITORS; LIPOPOLYSACCHARIDES; MICROGLIA; NEUTRALIZATION TESTS; NITRIC OXIDE; RATS; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032006604     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199802)22:2<130::AID-GLIA4>3.0.CO;2-B     Document Type: Article

References (67)

1. Adamson, D.C., Wildemann, B., Sasaki, M., Glass, J.D., McArthur, J.C., Christov, V.I., Dawson, T.M., and Dawson, V.L. (1996) Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science, 274:1917-1921.
2. Bagasra, O., Michaels, F.H., Zheng, Y.M., Bobroski, L.E., Spitsin, S.V., Fu, Z.F., Tawadros, R., and Koprowski, H. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl Acad. Sci. USA, 92:12041-12045.
3. Beebe, D.P., Wood, L.L., and Moos, M. (1990) Characterization of tissue plasminogen activator binding proteins isolated from endothelial cells and other cell types. Thromb. Res., 59:339-350.
4. Bizik, J., Lizonova, A., Stephens, R.W., Grofova, M., and Vaheri, A. (1990) Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha-2-macroglobulin secretion. Cell. Regulat., 1:895-905.
5. Blasi, F., Vassalli, J.D., and Dano, K. (1987) Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. [Review.] J. Cell. Biol., 104:801-804.
6. Blasi, F., Conese, M., Moller, L.B., Pedersen, N., Cavallaro, U., Cubellis, M., Fazioli, F., Hernandezmarero, L., Limongi, P., Munozcanoves, P., Resnati, M., Riitinen, L., Sidenius, N., Soravia, E., Soria, M.R., Stopelli, M.P., Talarico, D., Teesalu, T., and Valcamonica, S. (1994) The urokinase receptor: Structure, regulation, and inhibitor-mediated internalization. Fibrinolysis, 8:182-188.
7. Boje, K.M. and Arora, P.K. (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res., 587:250-256.
8. Boxman, I.L., Quax, P.H., Lowik, C.W., Papapoulos, S.E., Verheijen, J., and Ponec, M. (1995) Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts. J Invest. Dermatol., 104:374-378.
9. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72:248-254.
10. Brauer, P.R. and Yee, J.A. (1993) Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis. Dev. Biol., 155:281-285.
11. Brown, PD., Wakefield, L.M., Levinson, A.D., and Sporn, M.H. (1990) Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors, 3:35-41.
12. Busso, N., Belin, D., Failly-Crepin, C., and Vassalli, J.D. (1987) Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231. Cancer Res., 47:364-370.
13. Dallas, S.L., Miyazono, K., Skerry, T.M., Mundy, G.R., and Bonewald, L.F. (1995) Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matric protein. J. Cell. Biol., 131:539-549.
14. Dano, K., Behrendt, N., Brunner, N., Ellis, V., Ploug, M., and Pyke, C. (1994) The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis, 8:189-203.
15. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S., and Snyder, S.H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA, 88:6368-6371.
16. de Groot, C.J.A., Ruuls, S.R., Theeuwes, J.W.M., Dijkstra, C.D., and Van der Valk, P. (1997) Immunocytochemical expression of the inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol., 56:10-20.
17. Ding, A.H., Nathan, C.F., and Stuehr, D.J. (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophage. J. Immunol., 141:2407-2412.
18. Faber-Elman, A., Miskin, R., and Schwartz, M. (1995) Components of the plasminogen activator system in astrocytes are modulated by tumor necrosis factor-alpha and interleukin-1 beta through similar signal transduction pathways. J. Neurochem., 65:1524-1535.
19. Flanders, K.C., Lippa, C.F., Smith, T.W., Pollen, D.A., and Sporn, M.B. (1995) Altered expression of transforming growth factor-β in Alzheimer's disease. Neurology, 45:1561-1569.
20. Flaumenhaft, R., Abe, M., Mignatti, P., and Rifkin, D.B. (1992) Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J. Cell. Biol., 118:901-909.
21. Förstermann, U., Schmidt, H.H.H.W., Kohlhaas, K.L., and Murad, F. (1992) Induced RAW 264.7 macrophages express soluble and particulate nitric oxide synthase: inhibition by transforming growth factor-β. Eur. J. Pharmacol, 225:161-165.
22. Fort, P., Marty, L., Piechaczyk, M., ElSabroury, S., Dani, S., Jeanteur, P., and Blanchard, J.M. (1988) Various rat adult tissues express only one major mRNA species from the glyceraldehyde 3 phosphate dehydrogenase multigenic family. Nucleic Acids Res., 13:1431-1442.
23. Gehrmann, J., Matsumoto, Y., and Kreutzberg, G.W. (1995) Microglia: Intrinsic immuneffector cell of the brain. Brain Res. Rev., 209:269-287.
24. Giulian, D. (1987) Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res., 18:155-171.
25. Giulian, D. (1993) Reactive glia as rivals in regulating neuronal survival. GLIA 7:102-110.
26. Giulian, D., Young, D.G., Woodward, J., Brown, D.C., and Lachman, L.B. (1988) Interleukin-1 is an astroglial growth factor in the developing brain. J. Neumsci., 8:709-714.
27. Giulian, D., Johnson, B., Krebs, J.F., George, J.K., and Tapscott, M. (1991) Microglial mitogens are produced in the developing and injured mammalial brain. J. Cell. Biol., 112:323-333.
28. Giulian, D., Vaca, K., and Corpuz, M. (1993) Brain glia release factors with opposing actions upon neuronal survival. J. Neurasci., 13: 29-37.
29. Goldberg, W.J., Levine, K.V., Tadvalkar, G., Laws, E.R., Jr., and Bernstein, J.J. (1992) Mechanisms of C6 glioma cell and fetal astrocyte migration into hydrated collagen I gels. Brain Res., 581:81-90.
30. Gordon, S., Andersson, B., Lawson, L., and Perry, H. (1993) Differentiation and activation of macrophages and microglia in the Nervous system. Molecular and Cellular Mechanisms of Neural-Immune Interactions, IX:69-73.
31. Granelli-Piperno, A., and Reich, E. (1978) A study of proteases and protease-inhibitor complexes in biological fluids. J. Exp. Med., 148:223-234.
32. Kalderon, N., Ahonen, K., and Fedoroff, S. (1990) Developmental transition in plasticity properties of differentiating astrocytes: age-related biochemical profile of plasminogen activators in astroglial cultures. GLIA, 3:413-426.
33. Kojima, S., Vernooy, R., Moscatelli, D., Amanuma, H., and Rifkin, D.B. (1995) Lipopolysaccharide inhibits activation of latent transforming growth factor-beta in bovine endothelial cells. J. Cell. Physiol., 163:210-219.
34. Koka, P., He, K., Zack, J.A., Kitchen, S., Peacock, W., Fried, I., Tran, T., Yashar, S.S., and Merill, J.E. (1995) Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor α, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J. Exp. Med., 182:941-952.
35. Lee, S.C., Liu, W., Dickson, D.W., Brosnan, C.F., and Berman, J.W. (1993) Cytokine production by human fetal microglia and astrocytes, J. Immunol., 150:2659-2667.
36. Lee, S.C., Liu, W.L., Brosnan, C.F., and Dickson, D.W. (1994) GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. GLIA, 12:309-318.
37. Lijnen, H.R., Bachmann, F., Collen, D., Ellis, V., Pannekoek, H., Rijken, D.C., and Thorsen, S. (1994) Mechanisms of plasminogen activation. J. Int. Med., 236:415-424.
38. Lindholm, D., Castren, E., Kiefer, R., Zafra, F., and Thoenen, H. (1992) Transforming growth factor-β1 in the rat brain: Increase after injury and inhibition of astrocyte proliferation. J. Cell. Biol., 117:395-400.
39. Lyons, R.M., Keski-Oja, J., and Moses, H.L. (1988) Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J. Cell. Biol., 106:1659-1665.
40. Lyons, R.M., Gentry, L.E., Purchio, A.F., and Moses, H.L. (1990) Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell. Biol., 110:1361-1367.
41. Murphy, P. and Hart, D.A. (1992) Modulation of plasminogen activator and plasminogen activator inhibitor expression in the human U373 glioblastoma/astrocytoma cell line by inflammatory mediators. Exp. Cell. Res., 198:93-100.
42. Nagata, K., Nakajima, K., and Kohsaka, S. (1993) Plasminogen promotes the development of rat mesencephalic dopaminergic neurons in vitro. Brain Res. Dev., 75:31-37.
43. Nakajima, K., Shimojo, M., Hamanoue, M., Ishiura, S., Sugita, H., and Kohsaka, S. (1992a) Identification of elastase as a secretory protease from cultured rat microglia. J. Neurochem., 58:1401-1408.
44. Nakajima, K., Tsuzaki, N., Nagata, K., Takemoto, N., and Kohsaka, S. (1992b) Production and secretion of plasminogen in cultured rat brain microglia. FEBS Lett., 308:179-182.
45. Nakajima, K., Tsuzaki, N., Shimojo, M., Hamanoue, M., and Kohsaka, S. (1992c) Microglia isolated from rat brain secrete a urokinase-type plasminogen activator. Brain Res., 577:285-292.
46. Nottet, H.S.L.M. and Gendelman, H.E. (1995) Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol. Today, 16:441-448.
47. Nunes, I., Shapiro, R.L., and Rifkin, D.B. (1995) Characterization of latent TGF-beta activation by murine peritoneal macrophages. J. Immunol., 155:1450-1459.
48. Nuovo, G.J. and Alfieri, M.L. (1996) AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Molecular Medicine, 2:358-366.
49. Odekon, L.E., Blasi, F., and Rifkin, D.B. (1994) Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. J. Cell. Physiol., 158:398-407.
50. Quax, P.H.A., van den Hoogen, C.M., Verheijen, J.H., Padro, T., Zeheb, R., Gelehrter, T.D., van Berkel, Th.J.C., Kuiper, J., and Emeis, J.J. (1990) Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J. Biol. Chem., 265:15560-15563.
51. Rogister, B., Leprince, P., Pettmann, B., Labourdette, G., Sensenbrenner, M., and Moonen, G. (1988) Brain basic fibroblast growth factor stimulates the release of plasminogen activators by newborn rat cultured astroglial cells. Neurosci. Lett., 91:321-326.
52. Rogister, B., Leprince, P., Delree, P., Van Damme, J., Billiau, A., and Moonen, G. (1990) Enhanced release of plasminogen activator inhibitor(s) but not of plasminogen activators by cultured rat glial cells treated with interleukin-1. GLIA, 3:252-257.
53. Sebire, G., Emilie, D., Wallon, C., Hery, C., Devergne, O., Delfraissy, J.F., Galanaud, P., and Tardieu, M. (1993) In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. J. Immunol., 150:1517-1523.
54. Spranger, M., Lindholm, D., Bandtlow, C., Heumann, R., Gnahn, H., Naher-Noe, M., and Thoenen, H. (1990) Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures in vivo. Eur. J. Neurosci., 2:69-76.
55. Sprengers, E.D. and Kluft, C. (1987) Plasminogen activator inhibitors. Blood, 69:381-387.
56. Toshniwal, P.K., Firestone, S.L., Barlow, G.H., and Tiku, M.L. (1987) Characterization of astrocyte plasminogen activator. J Neurol. Sci., 80:277-287.
57. Tranque, P., Robbins, R., Naftolin, F., and Andrade-Gordon, P. (1992) Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes. GLIA, 6:163-171.
58. Tranque, P., Naftolin, F., and Robbins, R. (1994) Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-I and epidermal growth factor. Endocrinology, 134:2606-2613.
59. Vassalli, J.D. (1994) The urokinase receptor. Fibrinolysis, 8:172-181.
60. Vassalli, J.D. and Belin, D. (1987) Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett., 214:187-191.
61. Vincent, V.A.M., Van Dam, A.-M., Persoons, J.H.A., Schotanus, K., Steinbusch, H.W.M., Schoffelmeer, A.N.M., and Berkenbosch, F. (1996) Gradual inhibition of inducible nitric oxide synthase but not of interleukin-1β production in rat microglial cells of endotoxin-treated mixed glial cell cultures. GLIA, 17:94-102.
62. Vincent, V.A.M., Tilders, F.J.H., and Van Dam, A.-M. (1997) Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor β. GLIA, 19:190-198.
63. Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q.-W., and Nathan, C. (1993) Mechanism of suppression of macrophage nitric oxide release by transforming growth factor β. J. Exp. Med., 178:605-613.
64. Wahl, S.M., Allen, J.B., McCartney-Francis, N., Morganti-Kossmann, M.C., Kossmann, T., Ellingsworth, L., Mai, U.E.H., Mergenhagen, S.E., and Orenstein, J.M. (1991) Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. Exp. Med., 173:981-991.
65. Wun, T.C. and Reich, E. (1987) An inhibitor of plasminogen activation from human placenta. Purification and characterization. J. Biol. Chem., 262:3646-3653.
66. Yee, J.A., Yan, L., Dominguez, J.C., Allan, E.H., and Martin, T.J. (1993) Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells. J. Cell. Physiol., 157:528-534.
67. Zeheb, R. and Gelehrter, T.D. (1988) Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene, 73:459-468.